Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George G Sokos

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Vascular Health and Risk Management|February 6, 2020
Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartanGeorge G Sokos, Amresh Raina
Infectious Disease Reports|January 29, 2014
Concomitant cat scratch disease and squamous cell carcinoma in a cardiac transplantNitin Bhanot, George G Sokos, Raymond L Benza, et al.
The Annals of Pharmacotherapy|July 15, 2010
Worsening heart failure in the setting of dronedarone initiationJames C Coons, Kara M Plauger, Amy L Seybert, et al.
JACC. Case Reports|July 28, 2021
Beyond the Diagnosis of Group IV Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension MimickersNoor Rehman Chima, Mohammed Osman, George G Sokos, et al.
Journal of Cardiac Failure|December 19, 2006
Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failureGeorge G Sokos, Lazaros A Nikolaidis, Sunil Mankad, et al.
Journal of Pharmacy Practice|August 4, 2022
Evaluating Guideline Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction Post-coronary Artery Bypass GraftingGalen M Kabulski, Troy Boughner, Thomas W Szymanski, et al.
Circulation|February 26, 2004
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusionLazaros A Nikolaidis, Sunil Mankad, George G Sokos, et al.
Recent Patents on Cardiovascular Drug Discovery|June 10, 2008
Conivaptan: potential therapeutic implications in heart failureStephen Y Chen, Zuheir Abrahams, George G Sokos, et al.
AIDS (London, England)|March 5, 2008
Antigenic stimulation in the simian model of HIV infection yields dilated cardiomyopathy through effects of TNFalphaJennifer H Yearley, Keith G Mansfield, Angela A L Carville, et al.
JACC. Heart Failure|December 27, 2016
Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device ImplantationHayah Kassis, Krishna Cherukuri, Richa Agarwal, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Vascular Health and Risk Management|February 6, 2020
Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartanGeorge G Sokos, Amresh Raina
Infectious Disease Reports|January 29, 2014
Concomitant cat scratch disease and squamous cell carcinoma in a cardiac transplantNitin Bhanot, George G Sokos, Raymond L Benza, et al.
The Annals of Pharmacotherapy|July 15, 2010
Worsening heart failure in the setting of dronedarone initiationJames C Coons, Kara M Plauger, Amy L Seybert, et al.
JACC. Case Reports|July 28, 2021
Beyond the Diagnosis of Group IV Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension MimickersNoor Rehman Chima, Mohammed Osman, George G Sokos, et al.
Journal of Cardiac Failure|December 19, 2006
Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failureGeorge G Sokos, Lazaros A Nikolaidis, Sunil Mankad, et al.
Journal of Pharmacy Practice|August 4, 2022
Evaluating Guideline Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction Post-coronary Artery Bypass GraftingGalen M Kabulski, Troy Boughner, Thomas W Szymanski, et al.
Circulation|February 26, 2004
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusionLazaros A Nikolaidis, Sunil Mankad, George G Sokos, et al.
Recent Patents on Cardiovascular Drug Discovery|June 10, 2008
Conivaptan: potential therapeutic implications in heart failureStephen Y Chen, Zuheir Abrahams, George G Sokos, et al.
AIDS (London, England)|March 5, 2008
Antigenic stimulation in the simian model of HIV infection yields dilated cardiomyopathy through effects of TNFalphaJennifer H Yearley, Keith G Mansfield, Angela A L Carville, et al.
JACC. Heart Failure|December 27, 2016
Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device ImplantationHayah Kassis, Krishna Cherukuri, Richa Agarwal, et al.
Pageof 2